Atlas FDA

Supartz FX, Visco-3

FDA premarket approval P980044/S045 · decided 2018-05-25

Approval details

PMA number
P980044
Supplement
S045
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Supartz FX, Visco-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2018-04-25
Decision date
2018-05-25
Days to decision
30 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Installation of a clean booth to be used in the processing of a syringe component for SUPARTZ FX and VISCO-3.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15